Lilly Expands U.S. Injectable Manufacturing With $3.5B Site
INDIANAPOLIS / LEHIGH VALLEY, Pa., Jan. 30, 2026 — Eli Lilly announced plans to invest more than $3.5 billion...
drug-device combination
Advertisement
FDA Clears KORU FreedomEDGE for RYSTIGGO Infusion
MAHWAH, N.J., January 29, 2026 — KORU Medical Systems has received U.S. FDA 510(k) clearance expanding the labeled use...
FDA Expands PearlMatrix Use Across Lumbar Fusion Procedures
Westminster, Colo., Jan. 13, 2026 — Cerapedics Inc. announced that the U.S. Food and Drug Administration (FDA) has approved...
Amphastar Secures FDA Approval for Teriparatide Injection
RANCHO CUCAMONGA, Calif. — December 15, 2025 — Amphastar Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration...
Advertisement
